Stifel Financial’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-20,683
| Closed | -$4.49M | – | 3426 |
|
|
2021
Q1 | $4.49M | Sell |
20,683
-25,556
| -55% | -$4.8M | 0.01% | 1023 |
|
|
2020
Q4 | $5.34M | Buy |
46,239
+3,216
| +7% | +$360K | 0.01% | 856 |
|
|
2020
Q3 | $4.19M | Sell |
43,023
-1,421
| -3% | -$164K | 0.01% | 855 |
|
|
2020
Q2 | $5.45M | Buy |
44,444
+110
| +0.2% | +$12.5K | 0.01% | 696 |
|
|
2020
Q1 | $3.9M | Sell |
44,334
-5,879
| -12% | -$623K | 0.01% | 750 |
|
|
2019
Q4 | $5.23M | Buy |
50,213
+16,408
| +49% | +$1.84M | 0.01% | 863 |
|
|
2019
Q3 | $3.91M | Buy |
33,805
+7,176
| +27% | +$1.09M | 0.01% | 940 |
|
|
2019
Q2 | $4.57M | Buy |
26,629
+2,274
| +9% | +$393K | 0.01% | 895 |
|
|
2019
Q1 | $4.1M | Sell |
24,355
-4,906
| -17% | -$730K | 0.01% | 892 |
|
|
2018
Q4 | $2.85M | Sell |
29,261
-2,605
| -8% | -$342K | 0.01% | 994 |
|
|
2018
Q3 | $5.51M | Buy |
31,866
+10,268
| +48% | +$1.48M | 0.02% | 798 |
|
|
2018
Q2 | $3M | Buy |
21,598
+5,300
| +33% | +$753K | 0.01% | 1016 |
|
|
2018
Q1 | $1.84M | Sell |
16,298
-2,198
| -12% | -$276K | 0.01% | 1215 |
|
|
2017
Q4 | $2.45M | Buy |
18,496
+1,061
| +6% | +$125K | 0.01% | 1064 |
|
|
2017
Q3 | $1.76M | Sell |
17,435
-1,281
| -7% | -$137K | 0.01% | 1189 |
|
|
2017
Q2 | $1.89M | Buy |
18,716
+3,676
| +24% | +$396K | 0.01% | 1130 |
|
|
2017
Q1 | $1.81M | Buy |
15,040
+4,094
| +37% | +$502K | 0.01% | 1124 |
|
|
2016
Q4 | $1.22M | Buy |
10,946
+6,064
| +124% | +$730K | 0.01% | 1288 |
|
|
2016
Q3 | $650K | Sell |
4,882
-3,698
| -43% | -$353K | ﹤0.01% | 1576 |
|
|
2016
Q2 | $786K | Buy |
8,580
+3,182
| +59% | +$268K | ﹤0.01% | 1497 |
|
|
2016
Q1 | $390K | Buy |
5,398
+1,936
| +56% | +$106K | ﹤0.01% | 1719 |
|
|
2015
Q4 | $240K | Buy |
3,462
+608
| +21% | +$49.5K | ﹤0.01% | 2027 |
|
|
2015
Q3 | $260K | Sell |
2,854
-510
| -15% | -$56.7K | ﹤0.01% | 1889 |
|
|
2015
Q2 | $412K | Sell |
3,364
-873
| -21% | -$99K | ﹤0.01% | 1787 |
|
|
2015
Q1 | $386K | Buy |
+4,237
| New | +$344K | ﹤0.01% | 1760 |
|
|
2014
Q3 | – | Sell |
-2,655
| Closed | -$285K | – | 2350 |
|
|
2014
Q2 | $285K | Buy |
+2,655
| New | +$185K | ﹤0.01% | 1811 |
|
Other funds holding GWPH
Stifel Financial's GWPH Position: Q2 2021 in Review
Stifel Financial sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 20,683 shares — an estimated $4.49M sold.
Stifel Financial first reported a position in GWPH in Q2 2014 and held it in 26 quarters. The position peaked at $5.51M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Stifel Financial reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Stifel Financial sold 20,683 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $4.49M.
- Stifel Financial first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 26 quarters.
- Stifel Financial's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5.51M in Q3 2018.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Stifel Financial's 13F filing for Q2 2021, filed 13 Aug 2021.